Thank you, Mr. Chair.
Thank you, all, for coming. That was all very interesting testimony.
This is directed to two of our witnesses, Dr. de Villa and Dr. Thomas. You both talked about harm reduction, particularly for injected drugs, and the use of safe consumption sites as part of health reduction, by no means as a long-term strategy, but as a short-term strategy.
Would either of you be able to give us an estimate on the yearly budget? How much does it cost at a harm reduction site, just the component that is for the safe injection site? Is there any estimate as to what that component of it costs in a year?